Integrative Pharmacology and Systems Neuroscience Research Group, IMIM, Hospital del Mar Medical Research Institute, Doctor Aiguader 88, 08003, Barcelona, Spain.
Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto Salud Carlos III, 28029, Madrid, Spain.
Curr Atheroscler Rep. 2020 Jul 17;22(9):47. doi: 10.1007/s11883-020-00863-7.
The goal is to review the connection between gut microbiota and cardiovascular disease, with specific emphasis on bile acids, and the influence of diet in modulating this relationship.
Bile acids exert a much broader range of biological functions than initially recognized, including regulation of cardiovascular function through direct and indirect mechanisms. There is a bi-directional relationship between gut microbiota modulation of bile acid-signaling properties, and their effects on gut microbiota composition. Evidence, primarily from rodent models and limited human trials, suggest that dietary modulation of the gut microbiome significantly impacts bile acid metabolism and subsequently host physiological response(s). Available evidence suggests that the link between diet, gut microbiota, and CVD risk is potentially mediated via bile acid effects on diverse metabolic pathways. However, further studies are needed to confirm/expand and translate these findings in a clinical setting.
本综述旨在探讨肠道微生物群与心血管疾病的关系,特别关注胆汁酸,以及饮食在调节这种关系中的作用。
胆汁酸发挥的生物学功能比最初认识到的要广泛得多,包括通过直接和间接机制调节心血管功能。肠道微生物群调节胆汁酸信号特性及其对肠道微生物群组成的影响之间存在双向关系。主要来自啮齿动物模型和有限的人体试验的证据表明,饮食对肠道微生物群的调节显著影响胆汁酸代谢,进而影响宿主的生理反应。现有证据表明,饮食、肠道微生物群和 CVD 风险之间的联系可能是通过胆汁酸对多种代谢途径的影响来介导的。然而,需要进一步的研究来确认/扩展和将这些发现转化到临床环境中。